BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSGMedical - Healthcare Information Services
+$0.29 today
- Market cap
- $13.60B
- Beta
- 1.87
- P/E (TTM)
- 56.0
- EPS (TTM)
- $1.15
Volume 1.77M
Average 2.99M
BTSG Net Income
Bottom-line profit after all expenses, interest, and taxes.
BrightSpring Health Services, Inc. Common StockNASDAQ: BTSG
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income grows, but more slowly than its trailing trend
Q3 FY2026 net income of $100.14M rose 79.3% year over year, behind the +161.1% change in trailing-twelve-month net income. Sequentially, it rose 15.5% from the prior quarter.
Context
- Net income amounted to 1.5% of revenue in FY2025, up 1.3 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 13 analysts of $417.99M (+119.2%) for the fiscal year ending Dec 2026, a slowdown from the +1155.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $100.14M+15.5% QoQ
- Last fiscal yearDec 2025
- $190.67M+1155.6% YoY
- LTMSep 2026
- $338.34M+161.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +79.3% | +58.3% | -21.0 pp |
| 1 year | +1155.6% | +119.2% | -1036.4 pp |
| 3-year CAGR | — | +51.3% | — |
| 5-year CAGR | +44.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- 190.67M USD
- Year-over-year change
- +1155.6%
- 4-year CAGR
- +39.9%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 190.67M | +1155.6% |
| FY2024 | 2024-12-31 | (18.06M) | +88.3% |
| FY2023 | 2023-12-31 | (154.6M) | -186.8% |
| FY2022 | 2022-12-31 | (53.91M) | -208.2% |
| FY2021 | 2021-12-31 | 49.8M | — |
Net Income vs competitors
How BTSG compares with its peers on the latest reported figures
- BTSG's LTM Sep 2026 net income of $338.34M is the highest of the 4 companies compared; the peer median is $50.6M.
- Its year-over-year change of +161.1% is the 2nd highest of 4, against a peer median of -5.3%.
- Net income amounts to 2.2% of revenue for BTSG, versus a peer median of 6.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $338.34M | +161.1% | — | 2.2% | |
| LTM Jun 2026 | $274.99M | -5.3% | +2.0% | 10.6% | |
| LTM Jun 2026 | $50.6M | +413.3% | — | 3.2% | |
| LTM Sep 2026 | -$190.84M | -242.6% | — | 6.7% | |
| Peer median (excluding BTSG) | $50.6M | -5.3% | +2.0% | 6.7% | |
Competitors are the stored peer set for BTSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.7B | 7.72B | 8.83B | 11.27B | 12.91B |
| Cost of Revenue | 5.45B | 6.37B | 7.39B | 9.68B | 11.39B |
| Gross Profit | 1.25B | 1.35B | 1.43B | 1.59B | 1.52B |
| Gross Margin | 18.6% | 17.5% | 16.2% | 14.1% | 11.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.01B | 1.13B | 1.29B | 1.38B | 1.22B |
| Operating Expenses | 1.01B | 1.17B | 1.29B | 1.38B | 1.22B |
| Depreciation & Amortization | 199.16M | 203.97M | 202.34M | 204.48M | 164.28M |
| EBITDA | 433.34M | 391.8M | 349.52M | 398.13M | 459.53M |
| EBITDA Margin | 6.5% | 5.1% | 4.0% | 3.5% | 3.6% |
| Operating Income | 234.18M | 187.83M | 147.18M | 206.37M | 295.25M |
| Operating Margin | 3.5% | 2.4% | 1.7% | 1.8% | 2.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 165.32M | 233.58M | 324.59M | 228.39M | 157.31M |
| Other Income / Expenses | (165.32M) | (233.58M) | (324.59M) | (241.11M) | (157.31M) |
| Income Before Tax | 68.86M | (45.75M) | (177.41M) | (34.74M) | 137.94M |
| Pre-Tax Margin | 1.0% | -0.6% | -2.0% | -0.3% | 1.1% |
| Income Tax Expense | 17.6M | 8.47M | (20.58M) | (14.22M) | 33.15M |
| Net Income | 49.8M | (53.91M) | (154.6M) | (18.06M) | 190.67M |
| Net Margin | 0.7% | -0.7% | -1.8% | -0.2% | 1.5% |
| EPS (Basic) | 0.29 | (0.31) | (0.90) | (0.09) | 0.94 |
| EPS (Diluted) | 0.29 | (0.31) | (0.90) | (0.09) | 0.87 |
| Weighted Avg Shares | 171.19M | 171.19M | 171.19M | 193M | 202.56M |
| Weighted Avg Shares (Diluted) | 171.19M | 171.19M | 171.19M | 193M | 219.77M |
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
Intrinsic Alpha fair value
Locked
Current Price
$68.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.